Skip to content

Understanding the Military to Civilian Transition

VOTE FOR THIS TALK/SUBMISSION

You have 3 votes left in this category

SPEAKERS
Dr. John Wojcik Headshot
Dr. John Wojcik
Principal - Owner, Mission Next Consulting

FORMATBreakout Sessions

CATEGORYTransition - Preparing for Life After

LEVELBasic Understanding

Close to 65% of active-duty veterans leave their first civilian jobs within 24 months. The Mission Next consultants spent two years researching why veterans leave their first jobs. Our research showed that veterans struggle to synch or conform to the culture of their civilian organization and simply abandon their new civilian job. A successful transition relies on the ability to truly understand one’s core values and personal vision for this next phase. This crucial step creates the foundation for a successful transition. This program highlights the challenges that will be faced during the transition to the civilian workforce. It begins with a discussion about what the research revealed and includes practical advice that will make the transition smoother. If participants want to continue learning more about the topic, the presenter’s book, Mission Next, includes an entire toolkit to guide transitioning service members through every aspect of the process.

MAIN SPEAKER

Dr. John Wojcik Headshot

Dr. John Wojcik

Principal - Owner, Mission Next Consulting

Dr. John Wojcik has 32 years of service, retiring as a Colonel. He served as Judge Advocate and general counsel on active duty for 20 years. He served in Afghanistan, Liberia, and Latvia. His military awards include the Bronze Star Medal and the Meritorious Service Ribbon. John helped form a Veterans Treatment Court in Michigan and has taught at Cooley Law School since 2004. He has his Master of Strategic Studies from the Army War College. His Doctor of Business Administration included his dissertation on the hurdles that service members face when they transition to a civilian job.

Start reading now!

Get instant access to the latest magazine.